Though 2025 won't mark the return of astronauts into deep space as NASA had hoped, launchpads still will be scorching-hot from a procession of robotic spacecraft attempting to land on the moon. How ...
Bishop asked about upcoming events. Missling outlined the anticipated schizophrenia trial readout for ANAVEX 3-71 in the first half of 2025, the detailed ATTENTION-AD data presentation in April, and ...
Cubans celebrated the anticipated release of jailed protesters in a deal struck under US then-president Joe Biden. Now hope ...
Anavex Life Sciences (AVXL – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ram ...
Anavex’s newest patent will be expected to remain in force at least until July 2039, not including any patent term extensions. It will expand and supplement the current ANAVEX®2-73 ...
Anavex’s newest patent will be expected to remain in force at least until July 2039, not including any patent term extensions. It will expand and supplement the current ANAVEX®2-73 (blarcamesine) ...
The patent, dated January 15, 2025, is expected to protect the company's technology through July 2039. With this development, Allurion's U.S. patent count rises to 20, complementing its global tally ...
The patent is expected to provide protection through July 2039. With the issuance of this patent, the Company now has 20 patents issued in the U.S. and 59 patents issued globally. The Allurion ...
The patent, dated January 15, 2025, is expected to protect the company's technology through July 2039. With this development, Allurion's U.S. patent count rises to 20, complementing its global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback